Inherited erythrocyte phosphofructokinase deficiency: Molecular mechanism
✍ Scribed by J. Etiemble; Ch. Picat; J. Siméon; Ch. Blatrix; P. Boivin
- Publisher
- Springer
- Year
- 1980
- Tongue
- English
- Weight
- 828 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0340-6717
No coin nor oath required. For personal study only.
✦ Synopsis
Erythrocyte PFK activity 50--60% that of normal controls was found in a mother and her son, without muscular or hematological symptoms. The PFK activity of the mother's muscle was normal in fresh preparations and partially unstable to storage at 4 degrees C. Electrophoresis of muscle PFK revealed two bands, on normal and one abnormal with an anodic mobility greater than normal. Both patients were characterized as heterozygotes for an unstable muscle PFK. Unstable M'subunits disappeared in erythrocytes which are old cells devoid fo protein synthesis. Consequently an increased E/M subunit ratio leads to a distribution of the five isozymes different from that of normal erythrocytes. In these patients, we observed a loss of the M4 enzyme together with an increase in the E4 isozyme. The kinetic and immunologic data were compatible with these modifications. Isoelectric focusing of hemolysates from the two patients revealed an acidification of the main activity band, suggesting that an increase in E4 isozyme resulted in a change of the total electric charge.
📜 SIMILAR VOLUMES
A case of hereditary nonspherocytic hemolytic anemia associated with partial erythrocyte PFK deficiency without muscular symptoms is reported: erythrocyte enzyme activity in the propositus was 60% of normal. Kinetic studies of erythrocyte PFK revealed increased sensitivity to ATP inhibition and decr
Erythrocyte pyruvate kinase (PK) from 5 patients with cogenital non-spherocytic hemolytic and erythrocyte PK deficiency have been studied by immunological methods and electrofucusing. L type immunologically related PK was titrated in crude hemolysate with anti human liver L type PK rabbit serum and
A preoperative hemostasis study discovered a prolonged activated partial thromboplastin time in a 23-year-old Portuguese Caucasian woman without personal or past family history of hemorrhage or thrombosis. This was corrected by pooled plasma that excluded circulating anticoagulant. Activated partial